Cargando…

IGF1R and Src inhibition induce synergistic cytotoxicity in HNSCC through inhibition of FAK

Head and neck cancer is the sixth most common cancer worldwide with a 5-year survival of only 65%. Targeting compensatory signaling pathways may improve therapeutic responses and combat resistance. Utilizing reverse phase protein arrays (RPPA) to assess the proteome and explore mechanisms of synergi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lehman, Christine E., Spencer, Adam, Hall, Sarah, Shaw, Jeremy J. P., Wulfkuhle, Julia, Petricoin, Emanuel F., Bekiranov, Stefan, Jameson, Mark J., Gioeli, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144381/ https://www.ncbi.nlm.nih.gov/pubmed/34031486 http://dx.doi.org/10.1038/s41598-021-90289-1

Ejemplares similares

Combinatorial drug screening and molecular profiling reveal diverse mechanisms of intrinsic and adaptive resistance to BRAF inhibition in V600E BRAF mutant melanomas
por: Roller, Devin G., et al.
Publicado: (2015)

Inhibition of epithelial cell migration and Src/FAK signaling by SIRT3
por: Lee, Jaewon J., et al.
Publicado: (2018)

Shikonin induces apoptosis and inhibits migration of ovarian carcinoma cells by inhibiting the phosphorylation of Src and FAK
por: HAO, ZHENFENG, et al.
Publicado: (2015)

Src SUMOylation Inhibits Tumor Growth Via Decreasing FAK Y925 Phosphorylation
por: Wang, Jing, et al.
Publicado: (2017)

Overcoming EMT-associated resistance to anti-cancer drugs via Src/FAK pathway inhibition
por: Wilson, Catherine, et al.
Publicado: (2014)

Redistribution of Adhesive Forces through Src/FAK Drives Contact Inhibition of Locomotion in Neural Crest
por: Roycroft, Alice, et al.
Publicado: (2018)

Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases
por: Liu, Yuanbo, et al.
Publicado: (2010)

Corosolic Acid Inhibits Hepatocellular Carcinoma Cell Migration by Targeting the VEGFR2/Src/FAK Pathway
por: Ku, Chung-Yu, et al.
Publicado: (2015)

Cilengitide induces cellular detachment and apoptosis in endothelial and glioma cells mediated by inhibition of FAK/src/AKT pathway
por: Oliveira-Ferrer, Leticia, et al.
Publicado: (2008)

Overexpression of CEACAM6 activates Src-FAK signaling and inhibits anoikis, through homophilic interactions in lung adenocarcinomas
por: Kim, Eun Young, et al.
Publicado: (2022)

β-elemene inhibits non-small cell lung cancer cell migration and invasion by inactivating the FAK-Src pathway
por: Zhang, Hongbo, et al.
Publicado: (2021)

Cilengitide inhibits osteoclast adhesion through blocking the α(v)β(3)-mediated FAK/Src signaling pathway
por: Guo, Dan-yang, et al.
Publicado: (2023)

Simultaneous deactivation of FAK and Src improves the pathology of hypertrophic scar
por: Su, Linlin, et al.
Publicado: (2016)

Inhibition of the integrin/FAK signaling axis and c-Myc synergistically disrupts ovarian cancer malignancy
por: Xu, B, et al.
Publicado: (2017)

Nobiletin Inhibits Angiogenesis by Regulating Src/FAK/STAT3-Mediated Signaling through PXN in ER(+) Breast Cancer Cells
por: Sp, Nipin, et al.
Publicado: (2017)

Syndecan-1 knockdown inhibits glioma cell proliferation and invasion by deregulating a c-src/FAK-associated signaling pathway
por: Shi, Shuang, et al.
Publicado: (2017)

Systems Analysis of Adaptive Responses to MAP Kinase Pathway Blockade in BRAF Mutant Melanoma
por: Capaldo, Brian J., et al.
Publicado: (2015)

FAK competes for Src to promote migration against invasion in melanoma cells
por: Kolli-Bouhafs, K, et al.
Publicado: (2014)

MMP-11 promoted the oral cancer migration and FAK/Src activation
por: Hsin, Chung-Han, et al.
Publicado: (2017)

Synergistic Anti-Cancer Effects of AKT and SRC Inhibition in Human Pancreatic Cancer Cells
por: Ahn, Kang, et al.
Publicado: (2018)

Validation of a multicellular tumor microenvironment system for modeling patient tumor biology and drug response
por: Roller, Devin G., et al.
Publicado: (2021)

Ganoderiol A-Enriched Extract Suppresses Migration and Adhesion of MDA-MB-231 Cells by Inhibiting FAK-SRC-Paxillin Cascade Pathway
por: Wu, Guo-Sheng, et al.
Publicado: (2013)

Inhibition of STAT3, FAK and Src mediated signaling reduces cancer stem cell load, tumorigenic potential and metastasis in breast cancer
por: Thakur, Ravi, et al.
Publicado: (2015)

Silencing ZIC2 abrogates tumorigenesis and anoikis resistance of non-small cell lung cancer cells by inhibiting Src/FAK signaling
por: Liu, Aibin, et al.
Publicado: (2021)

D-pinitol Inhibits Prostate Cancer Metastasis through Inhibition of αVβ3 Integrin by Modulating FAK, c-Src and NF-κB Pathways
por: Lin, Tien-Huang, et al.
Publicado: (2013)

Artesunate and cisplatin synergistically inhibit HNSCC cell growth and promote apoptosis with artesunate‑induced decreases in Rb and phosphorylated Rb levels
por: Okamoto, Hiroki, et al.
Publicado: (2023)

Inhibition of GSK3α/β impairs the progression of HNSCC
por: Schulz, Lisa, et al.
Publicado: (2018)

Dissociation of FAK/p130(CAS)/c-Src Complex during Mitosis: Role of Mitosis-specific Serine Phosphorylation of FAK
por: Yamakita, Yoshihiko, et al.
Publicado: (1999)

Ambra1 spatially regulates Src activity and Src/FAK-mediated cancer cell invasion via trafficking networks
por: Schoenherr, Christina, et al.
Publicado: (2017)

Visualization of Src and FAK Activity during the Differentiation Process from HMSCs to Osteoblasts
por: Liao, Xiaoling, et al.
Publicado: (2012)

The dual kinase complex FAK-Src as a promising therapeutic target in cancer
por: Bolós, Victoria, et al.
Publicado: (2010)

The Effect of Differentiation Induction on FAK and Src Activity in Live HMSCs Visualized by FRET
por: Liao, Xiaoling, et al.
Publicado: (2013)

Modulation of FAK and Src adhesion signaling occurs independently of adhesion complex composition
por: Horton, Edward R., et al.
Publicado: (2016)

Eps8 controls Src- and FAK-dependent phenotypes in squamous carcinoma cells
por: Schoenherr, Christina, et al.
Publicado: (2014)

FAK-Copy-Gain Is a Predictive Marker for Sensitivity to FAK Inhibition in Breast Cancer
por: Kim, Young-Ho, et al.
Publicado: (2019)

Concurrent inhibition of FAK/SRC and MEK overcomes MEK inhibitor resistance in Neurofibromatosis Type I related malignant peripheral nerve sheath tumors
por: Gu, Yihui, et al.
Publicado: (2022)

Kinome Profiling of NF1-Related MPNSTs in Response to Kinase Inhibition and Doxorubicin Reveals Therapeutic Vulnerabilities
por: Grit, Jamie L., et al.
Publicado: (2020)

Co-inhibition of EGFR and IGF1R synergistically impacts therapeutically on adrenocortical carcinoma
por: Xu, Lieyu, et al.
Publicado: (2016)

SY-707, an ALK/FAK/IGF1R inhibitor, suppresses growth and metastasis of breast cancer cells: SY-707 is an ALK/FAK/IGF1R inhibitor
por: Liu, Ping, et al.
Publicado: (2022)

Cyclin G2 Inhibits Oral Squamous Cell Carcinoma Growth and Metastasis by Binding to IGFBP3 and Regulating the FAK-SRC-STAT Signaling Pathway
por: Wang, Danning, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2migip67nne1c042qpadhtksqa